- Global Pharma News & Resources

Stem Cell Cartilage Regeneration Market Growth Insights | Market is estimated to be valued at US$ 298.3 million in 2019 | by Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB


Stem cell-based therapy is a key focus in functional replacement of cartilage regeneration. In cartilage regeneration, stem cells have the potential for self-replication & multiple differentiation, making it an ideal choice for use as seed cells.

Request Here For Market Latest Insights:


Increasing demand for safe and effective treatment, such as stem cell therapy, due to the increasing prevalence of osteoarthritis around the world is expected to drive growth of the global stem cell cartilage regeneration market over the forecast period. According to the Arthritis Foundation, in 2017, more than 14 million Americans had symptomatic knee osteoarthritis and around 2 million American adults over 45 were suffering from symptomatic knee osteoarthritis

Moreover, increase in development of safe, viable, and efficient therapeutic agents for cartilage regeneration by market players is expected to propel the market growth. For instance, California’s Stem Cell Agency is developing new stem cell therapy for the treatment of chronic diseases. Furthermore, Fate Therapeutics and Sangamo Therapeutics are developing stem cell therapies to treat various disease, such as cancer and β-Thalassemia, respectively.


Market players are focused on adopting mergers and acquisitions (M&A) strategies to strengthen their market position or to strengthen their product portfolio, which in turn boost the growth of the global stem cell cartilage regeneration market. For instance, in 2015, FUJIFILM Holdings Corporation and Cellular Dynamics International, Inc. entered into a definitive agreement whereby Fujifilm will acquire Cellular Dynamics. This acquisition will allow Fujifilm to gain entry into the area of iPS cell-based drug discovery support services.

Key Players:

Key players active in the global stem cell cartilage regeneration market are Vericel Corporation, BioTissue SA, Osiris Therapeutics, Inc., Merck KGaA, CellGenix GmbH, Xintela AB, Orthocell Ltd., and Theracell Advanced Biotechnology Ltd.

Purchase this Report at Discount Of US $2000 Flat OFF –

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 21-Sep-2021